Press releaseNewsfile
BioHarvest Sciences
BHST · CANADIAN
$1.72+$0.04 (+2.38%)TodayMarket closed ·
Prev close $1.68
Latest news
- Press releaseNewsfile
Tate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
- Press releaseNewsfile
BioHarvest Sciences Announces Share Repurchase Program
- Press releaseNewsfile
BioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
- Press releaseNewsfile
BioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
- Press releaseNewsfile
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
- Press releaseNewsfile
BioHarvest Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseNewsfile
BioHarvest Secures 20-Ton Manufacturing and Supply Agreement for Rare Botanical Luxury Fragrance
- Press releaseNewsfile
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
- Press releaseNewsfile
BioHarvest Sciences to Report Second Quarter 2026 Financial Results on August 11, 2026
- Press releaseNewsfile
BioHarvest Awarded $1.4M Grant from the Israel Innovation Authority to Pioneer AI-Driven Plant-Cell Synthesis
- Press releaseNewsfile
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
- Press releaseNewsfile
BioHarvest Sciences to Present at the 2026 BIO International Convention
- Press releaseNewsfile
Tate & Lyle Expands Collaboration with BioHarvest Sciences to Accelerate Next-Generation Sweetener Innovation
- News
Earnings Scheduled For May 14, 2026
- Press releaseNewsfile
BioHarvest Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
- Press releaseNewsfile
BioHarvest Sciences Appoints New Head of Business Development for its CDMO Division
- Press releaseNewsfile
BioHarvest Sciences Announces Successful Completion of Stage 1 Development of Saffron Composition for Nutraceutical and Culinary Applications
- Press releaseNewsfile
BioHarvest Sciences Signs $1.2M CDMO Stage 2 Contract for the Development of a Rare Fragrance Using Its Proprietary Botanical Synthesis Platform
- Press releaseNewsfile
BioHarvest Sciences to Report First Quarter 2026 Financial Results on May 14, 2026
- Press releaseNewsfile
BioHarvest Sciences Announces Strategic Leadership Transition with Dr. Zaki Rakib Assuming Role of Chief Executive Officer to Accelerate "Two-Lens" Growth Strategy
- Press releaseNewsfile
BioHarvest Sciences Reports Fourth Quarter and Full-Year 2025 Financial Results
- Press releaseNewsfile
BioHarvest Sciences Announces First-Ever Successful Stable Cell Culture Development of Rare Fragrance-Producing Plant Using Proprietary Botanical Synthesis Platform
- News
Earnings Scheduled For March 31, 2026
- Press releaseNewsfile
BioHarvest Sciences Announces that VINIA is Now the No.1 Resveratrol Polyphenol Brand in the United States
- Press releaseNewsfile
BioHarvest Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 31, 2026
- Press releaseNewsfile
BioHarvest Sciences Announces Board Transition and Appointment of Prof. Hezi Levy
- Press releaseNewsfile
BioHarvest Sciences Reports Third Quarter 2025 Financial Results
- News
Earnings Scheduled For November 13, 2025
- Press releaseNewsfile
BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver Cells
- NewsVandana Singh
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells
- Press releaseNewsfile
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology
- NewsAnusuya Lahiri
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.